Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Neuspera Medical Inc. has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This matter is assigned to a distinct art unit, indicating a specific technical focus for the company's current medical device activity. The concentration in a specialized division suggests that the company's innovations are being evaluated within a single area, which may lead to a highly focused examination process.
The prosecution is handled by a distinct examiner, SAHAND, SANA, who is the busiest official for the portfolio with 1 pending action. The outcome of this company's current patent filing is dependent on the feedback and review of this specific examiner. Having only one official responsible for the entire active workload allows the legal team to focus exclusively on the specific preferences and procedural expectations of that individual.
While this centralized structure provides a clear point of contact, it also means the company's current prosecution success is tied to the perspective of the assigned reviewer. Practitioners should prioritize building a thorough understanding of the technical requirements and examination style favored by SAHAND, SANA. The outcome of the 1 pending action will be a significant indicator of the company's future trajectory within the Medical Devices & Mechanical Engineering sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAHAND, SANA | 1 | 63.5% | +24.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19079210 | TRIALING SYSTEM FOR SACRAL NEUROMODULATION THERAPY | SAHAND, SANA | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19079210 | TRIALING SYSTEM FOR SACRAL NEUROMODULATION THERAPY | SAHAND, SANA | 3796 | §103 | Non-Final OA | — | Pending | Mar 13, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNeuspera Medical Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sana Sahand has the most, with 1 of Neuspera Medical Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
